Segui
Seiichi Mori
Seiichi Mori
Genome Center, Japanese Foundation for Cancer Research
Email verificata su jfcr.or.jp
Titolo
Citata da
Citata da
Anno
Development of peripheral lymphoid organs and natural killer cells depends on the helix–loop–helix inhibitor Id2
Y Yokota, A Mansouri, S Mori, S Sugawara, S Adachi, SI Nishikawa, ...
Nature 397 (6721), 702-706, 1999
10321999
Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
TZ Tan, QH Miow, Y Miki, T Noda, S Mori, RYJ Huang, JP Thiery
EMBO molecular medicine 6 (10), 1279-1293, 2014
6602014
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
T Baba, PA Convery, N Matsumura, RS Whitaker, E Kondoh, T Perry, ...
Oncogene 28 (2), 209-218, 2009
5252009
A bistable Rb–E2F switch underlies the restriction point
G Yao, TJ Lee, S Mori, JR Nevins, L You
Nature cell biology 10 (4), 476-482, 2008
4982008
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor …
RYJ Huang, MK Wong, TZ Tan, KT Kuay, AHC Ng, VY Chung, YS Chu, ...
Cell death & disease 4 (11), e915-e915, 2013
4292013
Anchorage-independent cell growth signature identifies tumors with metastatic potential
S Mori, JT Chang, ER Andrechek, N Matsumura, T Baba, G Yao, JW Kim, ...
Oncogene 28 (31), 2796-2805, 2009
3882009
Role of Id family proteins in growth control
Y Yokota, S Mori
Journal of cellular physiology 190 (1), 21-28, 2002
3092002
An E2F1-dependent gene expression program that determines the balance between proliferation and cell death
TC Hallstrom, S Mori, JR Nevins
Cancer cell 13 (1), 11-22, 2008
2862008
The genomic analysis of lactic acidosis and acidosis response in human cancers
JLY Chen, JE Lucas, T Schroeder, S Mori, J Wu, J Nevins, M Dewhirst, ...
PLoS genetics 4 (12), e1000293, 2008
2302008
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
TZ Tan, QH Miow, RYJ Huang, MK Wong, J Ye, JA Lau, MC Wu, ...
EMBO molecular medicine 5 (7), 1051-1066, 2013
2172013
Lactation defect in mice lacking the helix–loop–helix inhibitor Id2
S Mori, SI Nishikawa, Y Yokota
The EMBO journal 19 (21), 5772-5781, 2000
1662000
Using a stem cell–based signature to guide therapeutic selection in cancer
I Shats, ML Gatza, JT Chang, S Mori, J Wang, J Rich, JR Nevins
Cancer research 71 (5), 1772-1780, 2011
1402011
A genomic strategy to elucidate modules of oncogenic pathway signaling networks
JT Chang, C Carvalho, S Mori, AH Bild, ML Gatza, Q Wang, JE Lucas, ...
Molecular cell 34 (1), 104-114, 2009
1392009
FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway
M Asad, MK Wong, TZ Tan, M Choolani, J Low, S Mori, D Virshup, ...
Cell death & disease 5 (7), e1346-e1346, 2014
1382014
A role for E2F6 in distinguishing G1/S-and G2/M-specific transcription
PH Giangrande, W Zhu, S Schlisio, X Sun, S Mori, S Gaubatz, JR Nevins
Genes & development 18 (23), 2941-2951, 2004
1362004
Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
QH Miow, TZ Tan, J Ye, JA Lau, T Yokomizo, JP Thiery, S Mori
Oncogene 34 (15), 1899-1907, 2015
1272015
SIRT2 down‐regulation in HeLa can induce p53 accumulation via p38 MAPK activation‐dependent p300 decrease, eventually leading to apoptosis
Y Li, H Matsumori, Y Nakayama, M Osaki, H Kojima, A Kurimasa, H Ito, ...
Genes to Cells 16 (1), 34-45, 2011
1262011
A novel Snail-related transcription factor Smuc regulates basic helix–loop–helix transcription factor activities via specific E-box motifs
H Kataoka, T Murayama, M Yokode, S Mori, H Sano, H Ozaki, Y Yokota, ...
Nucleic acids research 28 (2), 626-633, 2000
1232000
Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer
N Matsumura, Z Huang, S Mori, T Baba, S Fujii, I Konishi, ES Iversen, ...
Genome research 21 (1), 74-82, 2011
1052011
Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects
CQ Wang, V Krishnan, LS Tay, DWL Chin, CP Koh, JY Chooi, GSS Nah, ...
Cell reports 8 (3), 767-782, 2014
1032014
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20